<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="82132">
  <stage>Registered</stage>
  <submitdate>3/07/2007</submitdate>
  <approvaldate>10/07/2007</approvaldate>
  <actrnumber>ACTRN12607000365460</actrnumber>
  <trial_identification>
    <studytitle>The Journey Total Knee Athroplasty 'TKA' project: A comparison of two concepts for improved function of knee replacements.</studytitle>
    <scientifictitle>Patients with osteoarthritis (OA) requiring TKR will have better functional outcomes and satisfaction with the Journey knee when compared to the Genesis II PS knee as measured by degrees of flexion and Oxford Knee Score at 2 years.  </scientifictitle>
    <utrn />
    <trialacronym>N/A</trialacronym>
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Osteoarthrosis (OA)  of the knee.</healthcondition>
    <conditioncode>
      <conditioncode1>Musculoskeletal</conditioncode1>
      <conditioncode2>Osteoarthritis</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>The intervention is a total knee replacement with either the Journey TKA. Implants will use Oxinium femurs and be fully cemented standard tibia baseplate. The prothesis is permanently implanted.</interventions>
    <comparator>Genesis II PS knee prothesis</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Degrees of flexion   Objective outcome.</outcome>
      <timepoint>Assessed at Pre op,  6, 12, and 24 months.  6 minute walk test at 12 months. </timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Oxford Knee Score  Subjective outcome.</outcome>
      <timepoint>Assessed at Pre op,  6, 12, and 24 months.  6 minute walk test at 12 months. </timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>The migration pattern of the tibia trays.</outcome>
      <timepoint>Assessed at Pre op,  6, 12, 24 months</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Rate of complications.</outcome>
      <timepoint>Assessed at Pre op,  6, 12, 24 months</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Micro movements of polyethylene.</outcome>
      <timepoint>Assessed at Pre op,  6, 12, 24 months</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Physically active patients, affected by OA of one knee and scheduled for primary TKA. Consent to study.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>80</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria> Inflammatory or post trauma arthritis, Severe osteoporosis, steroid treatment, unclear reason for pain.  Previous infection. Non compliance to study, 'Body Mass Index' &gt;35,  &gt; 80 years, &lt; 80° flexion, &gt; 15° 'Fixed Flexion Deformity' or varus/ valgus deformity.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Sealed opaque envelopes</concealment>
    <sequence>Permuted block design</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures>All investigators involved i.e. (the assessor and the data analyst) , except operating surgeon, blinded to choice of implant.</designfeatures>
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>1/11/2006</anticipatedstartdate>
    <actualstartdate>6/11/2006</actualstartdate>
    <anticipatedenddate>2/11/2009</anticipatedenddate>
    <actualenddate>13/05/2010</actualenddate>
    <samplesize>240</samplesize>
    <actualsamplesize>240</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate>1/06/2012</anticipatedlastvisitdate>
    <actuallastvisitdate>26/06/2012</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>Perth Orthopaedic Institute</primarysponsorname>
    <primarysponsoraddress>Gate 3, Verdun St
NEDLANDS
WA 6009</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Smith &amp; Nephew, Inc</fundingname>
      <fundingaddress>85 Waterloo Road, North Ryde, NSW - 2113</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>N/A</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The specific aims are to compare Gen II and Journey TKA regarding :
Patient satisfaction and functional outcome 
The degree of postoperative knee flexion. 
3D kinematics of the knee joints
Gait pattern
The rate of complications and difficulties
The migration pattern of  the tibia trays</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Pacific Private Clinic</ethicname>
      <ethicaddress />
      <ethicapprovaldate>7/05/2007</ethicapprovaldate>
      <hrec>200714</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Perth Orthopaedic Institute</ethicname>
      <ethicaddress />
      <ethicapprovaldate>7/10/2006</ethicapprovaldate>
      <hrec>2006-076</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Repatriation General Hospital</ethicname>
      <ethicaddress />
      <ethicapprovaldate>1/11/2006</ethicapprovaldate>
      <hrec>44/06</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Prof</title>
      <name>Professor Bo Nivbrant</name>
      <address>Perth Orthopaedic Institute
Gate 3
Verdun St
Nedlands WA 6009</address>
      <phone>+61 8 93866211</phone>
      <fax />
      <email>nivbrant@cyllene.uwa.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Mr</title>
      <name>Mausam Doctor</name>
      <address>85 Waterloo Road, North Ryde, NSW - 2113</address>
      <phone>+61 2 98573999</phone>
      <fax>+61 2 98573900</fax>
      <email>mausam.doctor@smith-nephew.com</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name>Professor Bo Nivbrant</name>
      <address>Perth Orthopaedic Institute 
Gate 3, Verdun St
Nedlands WA 6009</address>
      <phone>+61 8 93866211</phone>
      <fax />
      <email>nivbrant@cyllene.uwa.edu.au </email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>